This study examined the 10-year hospitalization characteristics, economic patterns and early clinical outcomes of type B aortic dissection (TBAD) patients that underwent thoracic endovascular aortic repair (TEVAR) in one high-volume hospital in China.
Methods:
We performed a population-based retrospective analysis based on electronic medical record system data provided by Zhongshan Hospital Fudan University from 2009 to 2018.
Results:
We identified 1,367 cases of TBAD patients with TEVAR over the past decade. The total incidence of in-hospital complications was 7.6% (104 of 1,367), among which acute kidney injury (AKI) had the highest incidence (3.1%, 42 of 1,367). Aortic-related reintervention was performed in 7 patients (0.5%). The overall aortic-related in-hospital mortality rate was 2.7% (37 of 1,367) and had no significant time-varying trend (P = 0.2). Among these, 27% of in-hospital deaths were caused by retrograde type A dissection (RTAD). Chronic TBAD had a higher risk of in-hospital death versus acute TBAD, with a risk ratio of 2.69 (95% confidence interval [CI]: 1.19-6.09). Patients with hypertension (risk ratio 4.63, 95% CI: 1.38, 15.54) also had a higher in-hospital death risk. These 2 factors were also the predictive factors for the composite endpoint of in-hospital adverse events (risk ratio 2.17, 95% CI: 1.43, 3.29 and risk ratio 4.83, 95% CI: 1.90, 12.28, respectively), in addition to Marfan syndrome (risk ratio 4.05, 95% CI: 1.61, 10.19). The average length of hospitalization significantly declined during the past decade (annual percentage change -6.3%, 95% CI -8.2 to -4.3), and the stent-grafts (SGs) cost was the main expenditure of the total hospitalization costs.
Conclusion:
Our study showed a favorable early outcome of TEVAR over the past decade. Greater attention should be paid to certain risk factors in order to reduce the in-hospital adverse events. SG expenditure is still the primary economic burden on Chinese TBAD patients.
NienaberCACloughRE. Management of acute aortic dissection. Lancet. 2015;385(9970):800–811.
2.
HaganPGNienaberCAIsselbacherEM, et al.The international registry of acute aortic dissection (IRAD): new insights into an old disease. JAMA. 2000;283(7):897–903.
EvangelistaAIsselbacherEMBossoneE, et al.Insights from the international registry of acute aortic dissection: a 20-year experience of collaborative clinical research. Circulation. 2018;137(17):1846–1860.
5.
DakeMDKatoNMitchellRS, et al.Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med. 1999;340(20):1546–1552.
6.
FattoriRMontgomeryDLovatoL, et al.Survival after endovascular therapy in patients with type B aortic dissection: a report from the International registry of acute aortic dissection (IRAD). JACC Cardiovasc Interv. 2013;6(8):876–882.
7.
RiambauVBöcklerDBrunkwallJ, et al.Editor’s choice–management of descending thoracic aorta diseases: clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg. 2017;53(1):4–52.
8.
PapeLAAwaisMWoznickiEM, et al.Presentation, diagnosis, and outcomes of acute aortic dissection: 17-year trends from the international registry of acute aortic dissection. J Am Coll Cardiol. 2015;66(4):350–358.
9.
HsiehRWHsuTCLeeM, et al.Comparison of type B dissection by open, endovascular, and medical treatments. J Vasc Surg. 2019;70(6):1792–1800.
10.
NienaberCARousseauHEggebrechtH, et al.Randomized comparison of strategies for type B aortic dissection: the INvestigation of STEnt Grafts in aortic dissection (INSTEAD) trial. Circulation. 2009;120(25):2519–2528.
11.
HarkyAChanJSKWongCHMFrancisNGrafton-ClarkeCBashirM. Systematic review and meta-analysis of acute type B thoracic aortic dissection, open, or endovascular repair. J Vasc Surg. 2019;69(5):1599–1609. e2.
12.
BrunkwallJLammerJVerhoevenETaylorP. ADSORB: a study on the efficacy of endovascular grafting in uncomplicated acute dissection of the descending aorta. Eur J Vasc Endovasc Surg. 2012;44(1):31–36.
13.
BooherAMIsselbacherEMNienaberCA, et al.The IRAD classification system for characterizing survival after aortic dissection. Am J Med. 2013;126(8):730. e19-e24.
14.
JanuzziJLIsselbacherEMFattoriR, et al.Characterizing the young patient with aortic dissection: results from the International registry of aortic dissection (IRAD). J Am Coll Cardiol. 2004;43(4):665–669.
15.
WangDJFanFDWangQ, et al.Preliminary characterization of acute aortic dissection in the mainland of China. Chin Med J (Engl). 2011;124(11):1726–1730.
16.
WangWDuanWXueY, et al.Clinical features of acute aortic dissection from the registry of aortic dissection in China. J Thorac Cardiovasc Surg. 2014;148(6):2995–3000.
17.
LandenhedMEngstromGGottsaterA, et al.Risk profiles for aortic dissection and ruptured or surgically treated aneurysms: a prospective cohort study. JAMA. 2015;4(1):e001513.
18.
ErbelRAboyansVBoileauC, et al.2014 ESC Guidelines on the diagnosis and treatment of aortic diseases: document covering acute and chronic aortic diseases of the thoracic and abdominal aorta of the adult. The Task Force for the Diagnosis and Treatment of Aortic Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2014;35(41):2873–926.
19.
ZhuTSiYFangY, et al.Early outcomes of the conformable stent graft for acute complicated and uncomplicated type B aortic dissection. J Vasc Surg. 2017;66(6):1644–1652.
20.
LombardiJVHughesGCAppooJJ, et al.Society for Vascular Surgery (SVS) and society of thoracic surgeons (STS) reporting standards for type B aortic dissections. J Vasc Surg. 2020;71(3):723–747.
21.
FuW-GShiYWangY-Q, et al.Endovascular therapy for Stanford type B aortic dissection in 102 cases. Asian J Surg. 2005;28(4):271–276.
22.
DongZFuWWangY, et al.Stent graft-induced new entry after endovascular repair for Stanford type B aortic dissection. J Vasc Surg. 2010;52(6):1450–1457.
23.
SchlösserFJVerhagenHJLinPH, et al.TEVAR following prior abdominal aortic aneurysm surgery: increased risk of neurological deficit. J Vasc Surg. 2009;49(2):308–314.
24.
DeMartinoRRSenIHuangY, et al.Population-based assessment of the incidence of aortic dissection, intramural hematoma, and penetrating ulcer, and its associated mortality from 1995 to 2015. Circ Cardiovasc Qual Outcomes. 2018;11(8):e004689.
25.
TsaiTTTrimarchiSNienaberCA. Acute aortic dissection: perspectives from the International Registry of Acute Aortic Dissection (IRAD). Eur J Vasc Endovasc Surg. 2009;37(2):149–159.
26.
CigarroaJEIsselbacherEMDeSanctisRWEagleKA. Diagnostic imaging in the evaluation of suspected aortic dissection. Old standards and new directions. N Engl J Med. 1993;328(1):35–43.
27.
FattoriRCaoPDe RangoP, et al.Interdisciplinary expert consensus document on management of type B aortic dissection. J Am Coll Cardiol. 2013;61(16):1661–1678.
28.
TjadenBLJrSandhuHMillerC, et al.Outcomes from the gore global registry for endovascular aortic treatment in patients undergoing thoracic endovascular aortic repair for type B dissection. J Vasc Surg. 2018;68(5):1314–1323.
29.
InvestigatorsVR. The VIRTUE registry of type B thoracic dissections–study design and early results. Eur J Vasc Endovasc Surg. 2011;41(2):159–166.
30.
KangWCGreenbergRKMastracciTM, et al.Endovascular repair of complicated chronic distal aortic dissections: intermediate outcomes and complications. J Thorac Cardiovasc Surg. 2011;142(5):1074–1083.
31.
BrunkwallJKasprzakPVerhoevenE, et al.Endovascular repair of acute uncomplicated aortic type B dissection promotes aortic remodelling: 1 year results of the ADSORB trial. Eur J Vasc Endovasc Surg. 2014;48(3):285–291.
32.
QinY-LWangFLiT-X, et al.Endovascular repair compared with medical management of patients with uncomplicated type B acute aortic dissection. J Am Coll Cardiol. 2016;67(24):2835–2842.
33.
LeshnowerBGDuwayriYMChenEP, et al.Aortic remodeling after endovascular repair of complicated acute type B aortic dissection. Ann Thorac Surg. 2017;103(6):1878–1885.
34.
LouXChenEPDuwayriYM, et al.The impact of thoracic endovascular aortic repair on long-term survival in type B aortic dissection. Ann Thorac Surg. 2018;105(1):31–38.
35.
MaTDongZHFuWG, et al.Incidence and risk factors for retrograde type A dissection and stent graft-induced new entry after thoracic endovascular aortic repair. J Vasc Surg. 2018;67(4):1026–1033. e2.
36.
RodriguezJAOlsenDMLucasLWheatleyGRamaiahVDiethrichEB. Aortic remodeling after endografting of thoracoabdominal aortic dissection. J Vasc Surg. 2008;47(6):1188–1194.
37.
GuangqiCXiaoxiLWeiC, et al.Endovascular repair of Stanford type B aortic dissection: early and mid-term outcomes of 121 cases. Eur J Vasc Endovasc Surg. 2009;38(4):422–426.
38.
CloughRPatelALyonsO, et al.Pathology specific early outcome after thoracic endovascular aortic repair. Eur J Vasc Endovasc Surg. 2014;48(3):268–275.
39.
GilesKABeckAWLalaS, et al.Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection. J Vasc Surg. 2019;69(5):1367–1378.
40.
InvestigatorsVR. Mid-term outcomes and aortic remodelling after thoracic endovascular repair for acute, subacute, and chronic aortic dissection: the VIRTUE Registry. Eur J Vasc Endovasc Surg. 2014;48(4):363–371.
41.
FanelliFCannavaleAO’SullivanGJ, et al.Endovascular repair of acute and chronic aortic type B dissections: main factors affecting aortic remodeling and clinical outcome. JACC Cardiovasc Interv. 2016;9(2):183–191.
42.
EggebrechtHMehtaRHDecheneA, et al.Aortoesophageal fistula after thoracic aortic stent-graft placement: a rare but catastrophic complication of a novel emerging technique. JACC Cardiovasc Interv. 2009;2(6):570–576.
43.
WatermanALFeezorRJLeeWA, et al.Endovascular treatment of acute and chronic aortic pathology in patients with Marfan syndrome. J Vasc Surg. 2012;55(5):1234–1240; discussion 40-1.
